Navigating the high stakes of the bio-transition
The industrial biotechnology landscape is shifting. Whether you are developing novel biomass conversions, high-value enzymes, or complex biological strains, the path to market is increasingly compressed by:
-
The scaling gap: Moving from pilot to 200,000L+ vessels often reveals non-linear biological behaviours that can threaten nameplate capacity.
-
Regulatory evolution: The 2026 landscape of GMO regulations, carbon intensity (CI) scores, and EU digital product passports demands a new level of data transparency.
-
Margin compression: High utility demands for sterilisation and downstream processing can erode the price competitiveness of bio-based molecules against petrochemical benchmarks.
At Equans Sci-Tech, we recognise that a limited understanding of these critical process drivers poses a major risk to your investment. We act as your single source of accountability to turn these market challenges into your competitive advantage.
Your journey: from laboratory to full-scale manufacturing
The path to commercialising bio-based products is a high-stakes evolution. We join you at every critical milestone:
-
Laboratory & pilot stage: Identifying key success factors for scale-up feasibility early to ensure your process is viable.
-
Demonstrator phase: Refining technical workflows to prove commercial potential.
-
Industrial reality: Delivering an advanced manufacturing facility designed for high-volume, precision output.
Why choose Equans Sci-Tech
We replace fragmented procurement with a unified journey. Our approach ensures that your technical requirements are always aligned with your commercial outcomes through our core methodology:
Find the answers to your questions
The "utility intensity" is usually the greatest hurdle. Industrial-scale fermentation requires massive, consistent volumes of high-purity water, steam, and precise cooling. We design your infrastructure with the necessary redundancy to ensure that your biological batch is never compromised by a utility failure.
We specify and install high-grade stainless steel (316L) piping with orbital welding to eliminate "dead legs" where bacteria can grow. We then integrate fully automated Clean-in-Place (CIP) and Steam-in-Place (SIP) systems, allowing you to sterilize the entire production line without disassembly.
Yes. Our designs are modular. We create flexible "plug-and-play" utility service drops and adaptable downstream processing zones, allowing you to reconfigure the facility as your feedstock or biological process evolves.
We design integrated biowaste inactivation systems (kill-steps) and contained drainage to ensure that any genetically modified organisms (GMOs) or hazardous by-products are fully treated before leaving the facility, in strict compliance with environmental regulations.
Discover more
Scaling biotechnology from lab to plant requires a seamless transition from theory to practice. Discover how we lead this journey through expert Concept Design, followed by rigorous Project Management and final Commissioning to ensure your process is fully operational and compliant.
